MSH|^~\&|VA VDIF|8VA-002|ICARE|ICARE|20220901131443-0400||VXU^V04^VXU_V04|to220901181443694222|T|2.5.1|||ER|AL|||||Z22^CDCPHINVS|8VA-002|ICARE
PID|1||1013634402V344471^^^USVHA^MR||CDCIZGONE^ALPHAONE^^^^^L|LIZIZG^^^^^^M|20031201|F||2106-3^White^CDCREC|315 W 57TH ST^^NEW YORK^NY^10019-3158^USA^P^^36061||^PRN^PH^^^406^5557896|||||||||2186-5^NOT HISPANIC OR LATINO^CDCREC|||||||||||20220901131443
NK1|1|ALPHAONE^FRIEND^^^^^L|OTH^OTHER^HL70063
NK1|2|ALPHONE^FRIEND^^^^^L|OTH^OTHER^HL70063
ORC|RE||124769^984||||||||||||||8VA-002^DAYTON^HL70362
RXA|0|1|20220901||48^HIB (PRP-T)^CVX|999|||08^Historical information - from public Agency^NIP001||^^^8VA-002|||||||||CP|A
OBX|1|CE|64994-7^vaccine fund pgm elig cat^LN|1|V01^Not VFC elig^HL70064||||||F|||20220901|||VXC40^vaccine level^CDCPHINVS
OBX|2|CE|30963-3^Vaccine funding source^LN|1|VXC50^Public^HL70064||||||F|||20220901
